Drug-induced seizures

Adverse Drug Reaction Bulletin

Volumn , Issue 227, 2004, Pages

  Coleman, Jamie J ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BUTYROPHENONE; CENTRAL DEPRESSANT AGENT; CEPHALOSPORIN; CHLORPHENIRAMINE; CLOZAPINE; COCAINE; DIPHENHYDRAMINE; DOSULEPIN; ENFLURANE; FLUPHENAZINE; HALOPERIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; LITHIUM; LORATADINE; PENICILLIN DERIVATIVE; PHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; QUINOLONE DERIVATIVE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

4 AMINOBUTYRIC ACID METABOLISM; AGE DISTRIBUTION; ALCOHOL WITHDRAWAL; BRAIN DISEASE; BRAIN EDEMA; DRUG ABUSE; DRUG INDUCED DISEASE; DRUG OVERDOSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTOGENESIS; HEART ARRHYTHMIA; HUMAN; HYPERPYREXIA; HYPOGLYCEMIA; HYPONATREMIA; HYPOXIA; LIVER TOXICITY; NONHUMAN; POLYPHARMACY; REVIEW; RISK FACTOR; SEIZURE;

EID: 9144267891     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-200408000-00001     Document Type: Review

References (35)

1. Perkin GD. Epilepsy in later childhood and adults. In: Warrell DA, Cox TM, Firth JD, Benz EJ, editors. Oxford Textbook of Medicine, 4th ed. Oxford: Oxford University Press; 2003.
2. Boston Collaborative Drug Surveillance Program. Drug-induced convulsions. Lancet 1972; 2:677-679.
3. Young D, Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 1994; 58:245-261.
4. Pedata F, Mulas A, Pepeu IM, Pepeu G. Changes in regional brain acetylcholine levels during drug-induced convulsions. Europen Journal of Pharmacology 1976; 40:329-335.
5. Skowron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992; 12:18-22.
6. Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia 2002; 43 Suppl 2:8-13.
7. Schlienger RG, Klink MH, Eggenberger C, Drewe J. Seizures associated with therapeutic doses of venlafaxine and trimipramine. Annals of Pharmacotherapy 2000; 34:1402-1405.
8. Frazer A. Pharmacology of antidepressants. Journal of Clinical Psychopharmacology 1997; 17 Suppl 1:2S-18S.
9. Buckley NA, Dawson AH, Whyte IM, Henry DA. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994; 343:159-162.
10. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Quarterly Journal of Medicine 2003; 96:369-374.
11. Cox A, Anton C, Ferner RE. Take care with Zyban. Pharmaceutical Journal 2001; 266:718-722.
12. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39 Suppl 3:S2-S10.
13. Berkovic SF. Aggravation of generalized epilepsies. Epilepsia 1998; 39 Suppl 3:S11-S14.
14. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986; 27:706-710.
15. Ebert U. Basic mechanisms of psychotropic drugs. Epilepsia 2002; 43 Suppl 2:2-7.
16. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991; 41:369-371.
17. Centorrino F, Price BH, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics. American Journal of Psychiatry 2002; 159:109-115.
18. Zacarra G, Muscas GC, Messori A. Clinical features, pathogenesis and management of drug-induced seizures. Drug Safety 1990; 5:109-151.
19. Kamei C, Ohuchi M, Sugimoto Y, Okuma C. Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats. Brain Research 2000; 887:183-186.
20. Modica PA, Tempelhoff R, White PF. Pro and anticonvulsant effects of anesthetics (Part II). Anesthesia and Analgesia 1990; 70:433-434.
21. Hilty CA, Drummond JC. Seizure-like activity on emergence from sevoflurane anesthesia. Anesthesiology 2000; 93:1357-1359.
22. Walder BM, Tramer MRM, Seeck MM. Seizure-like phenomena and propofol: a systematic review. Neurology 2002; 58:1327-1332.
23. DeToledo JC. Lidocaine and seizures. Therapeutic Drug Monitoring 2000; 22:320-322.
24. Barrons RW, Murray KM, Richey RM. Populations at risk for penicillin-induced seizures. Annals of Pharmacotherapy 1992; 26:26-29.
25. Garcia PA, Alldredge BK. Drug-induced seizures. Neurologic Clinics 1994; 12:85-99.
26. Norrby SR. Carbapenems in serious infections: a risk-benefit assessment. Drug Safety 2000; 22:191-194.
27. Kushner JM, Peckman HJ, Snyder CR. Seizures associated with fluoroquinolones. Annals of Pharmacotherapy 2001; 35:1194-1198.
28. Walton GD, Hon JK, Mulpur TG. Ofloxacin-induced seizure. Annals of Pharmacotherapy 1997; 31:1475-1477.
29. Job ML, Arn SK, Strom JG, et al. Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations. Therapeutic Drug Monitoring 1994; 16:427-431.
30. Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet 1998; 352:383-390.
31. Treisman GJ, Kaplin AI. Neurologic and psychiatric complications of antiretroviral agents. AIDS 2002; 16:1201-1215.
32. Thomas RJM. Seizures and Epilepsy in the Elderly. Archives of Internal Medicine 1997; 157:605-617.
33. Franson KL, Hay DP, Neppe V, et al. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs and Aging 1995; 7:38-48.
34. Alldredge BKP. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999; 53 Suppl 2:S68-S75.
35. DVLA. Medical rules, neurological disorders. http://www.dvla.gov.uk/ at_a_glance/ ch1_neurological.htm [Accessed 21st September 2004].